Form D · Pharmaceuticals
7 OAKS PHARMACEUTICAL Corp
Easley, SC · CIK 0001521033
Offering snapshot reported Jun 6, 2011 · SEC filing
- Reported sold
- $1.61M Offering amount: $3M
- Investors reported
- 199 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 20, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 6, 2011 | Initial | $1,613,014 | No comparison | 199 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-160804
OFFERING OF UP TO 6,000,000 SHARES OF COMMON STOCK AT $0.50 PER SHARE AS WELL AS AN OPTION TO CONVERT PROMISSORY NOTES INTO COMMON STOCK SHARES FOR $0.50 PER SHARE.
N/A
Source: Form D, filed Jun 6, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ralph Kelley | Executive |
| John Minaudo | Director, Executive |
| James Negron | Executive |
| Daniel T. Stanley | Director, Executive |
| Jonathan M. Stanley | Director, Executive |
| Miriam Stanley | Director, Executive |
| David E. Stanley | Director, Executive |
| R. Thomas Stanley, Jr. | Director, Executive |
| R. Thomas Stanley, Sr. | Director, Executive |
| Ken Wells | Director, Executive |
| Jay West, Phd | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
161 Harry Stanley Drive
Easley, SC, 29640
Easley, SC, 29640